Indication
Muscle Spasticity
5 clinical trials
5 products
Product
Botulinum toxin type AProduct
MTR-601Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study of MTR-601 in Healthy Volunteers.Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Phase III, Prospective, Multicentre, Open Label, Extension Study Assessing the Long Term Safety and Efficacy of Repeated Treatment With DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral PalsyStatus: Completed, Estimated PCD: 2015-01-01
Clinical trial
A Phase III, Multicentre, Double Blind, Prospective, Randomised, Placebo Controlled Study Assessing the Efficacy and Safety of DYSPORT® Used in the Treatment of Lower Limb Spasticity in Children With Dynamic Equinus Foot Deformity Due to Cerebral PalsyStatus: Completed, Estimated PCD: 2014-02-01
Product
PlaceboClinical trial
Peripheral Modulation of Muscle Stiffness and SpasticityStatus: Recruiting, Estimated PCD: 2024-11-16
Product
HyaluronidaseClinical trial
Altering Activation Patterns in the Distal Upper Extremity After StrokeStatus: Active (not recruiting), Estimated PCD: 2019-08-01
Product
Cyproheptadine